Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19-Reference-Cited by-同舟云学术

Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19

Published:2021-04-06 Issue:5 Volume:21 Page:319-329
ISSN:1474-1733
Container-title:Nature Reviews Immunology
language:en
Short-container-title:Nat Rev Immunol

Author:

Bonaventura Aldo^ORCID,Vecchié Alessandra,Dagna Lorenzo,Martinod Kimberly^ORCID,Dixon Dave L.,Van Tassell Benjamin W.,Dentali Francesco,Montecucco Fabrizio^ORCID,Massberg Steffen^ORCID,Levi Marcel,Abbate Antonio

Publisher

Springer Science and Business Media LLC

Subject

Energy Engineering and Power Technology,Fuel Technology

Link

http://www.nature.com/articles/s41577-021-00536-9.pdf

Reference182 articles.

1. Pascarella, G. et al. COVID-19 diagnosis and management: a comprehensive review. J. Intern. Med. 288, 192–206 (2020).

2. Bonaventura, A. et al. Targeting GM-CSF in COVID-19 pneumonia: rationale and strategies. Front. Immunol. 11, 1625 (2020).

3. McFadyen, J. D., Stevens, H. & Peter, K. The emerging threat of (micro)thrombosis in COVID-19 and its therapeutic implications. Circ. Res. 127, 571–587 (2020).

4. Ranucci, M. et al. The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome. J. Thromb. Haemost. 18, 1747–1751 (2020).

5. Gupta, A. et al. Extrapulmonary manifestations of COVID-19. Nat. Med. 26, 1017–1032 (2020).

Cited by 677 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tocilizumab reduces hypercoagulation in COVID-19 – Perspectives from the coagulation and immunomodulation Covid assessment (Coag-ImmCovA) clinical trial;Thrombosis Research;2024-11

2. Imaging and Biomarkers: The Assesment of Pulmonary Embolism Risk and Early Mortality;Medicina;2024-09-12

3. Decreased Protein C Pathway Activity in COVID-19 Compared to Non-COVID Sepsis: An Observational and Comparative Cohort Study;Biomedicines;2024-09-02

4. Ocular manifestations of COVID-19;Progress in Retinal and Eye Research;2024-09

5. Secondary infection after COVID-19;COVID-19: An Update;2024-09-01